Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 19, 2002BMJOpen Access

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJonathan J DeeksUniversity of Bern

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jonathan J Deeks (2002) studied this question.

synapsesocial.com/papers/6a7cd0dbc2bfb97ee802b54bhttps://doi.org/10.1136/bmj.325.7365.619
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Researchers deny any attempt to mislead the public over JAMA article on arthritis drug2001 · 14 citations
  2. 2Emergency admissions for upper gastrointestinal disease and their relation to NSAID use1997 · 169 citations
  3. 3Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis1999 · 806 citations
  4. 4Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis2000 · 4,051 citations
  5. 5Evaluation of the Functional Status Aspects of Health‐Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib1999 · 98 citations